Table of Contents

CVM CRADA Abstracts

The Food and Drug Administration (FDA) is actively interested in partnering with the private sector through arrangements which leverage FDA assets and resources and provide opportunities for the private sector to participate in the development, financing, ownership and operation of a public facility or service.

A Cooperative Research and Development Agreement (CRADA) is an agreement between one or more FDA Centers/Laboratories and one or more non-Federal parties under which the FDA Center/Laboratory provides personnel, services, facilities, equipment, or other resources toward the conduct of specified research or development efforts. Such research must be consistent with the mission of the Center/Laboratory. The CRADA partner contributes all of the above and funding to the project. CRADAs are appropriate only with collaborators who will make significant intellectual contributions to the research project or will contribute essential research materials or technical resources not otherwise reasonably available to FDA. See CRADA Policies and Points to Consider for additional information.

Technology transfer in FDA and throughout the Federal Government encourages partnerships for collaborative research and development. Such partnerships may strengthen the Agency's research efforts and increase resources for mission-related projects while benefiting the public, the Agency, and the scientist. Fair access and conflict of interest policies apply. See the FDA Technology Transfer Page for additional information.

Abstracts of the Center for Veterinary Medicine's (CVM) CRADAs are listed below.

Collaboration on Quality of Animal Drug Submissions (QUADS)

CVM A-Z Index | Contact CVM | About CVM | Site Map
FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA | Privacy | Accessibility | HHS Home Page